Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel oncolytic immunotherapies. We imagine a world where cancer is a curable disease.
| Website | http://www.replimune.com |
| Ticker | REPL |
| Revenue | $234.5 million |
| Funding | $376 million |
| Employees | 416 (369 on RocketReach) |
| Founded | 2015 |
| Address | 500 Unicorn Park Dr Fl 3, Woburn, Massachusetts 01801, US |
| Phone | +1 781-222-9600 |
| Technologies |
JavaScript
,
HTML
,
PHP
+36 more
(view full list)
|
| Industry | Biotechnology Research, Pharmaceuticals, Health Care, Biotechnology, Healthcare, Medical, Therapeutics |
| Competitors | Novartis, Merck AH, Pfizer, Sanofi, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen, Regeneron, Gilead Sciences +36 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Replimune employee's phone or email?
The Replimune annual revenue was $234.5 million in 2026.
Sushil Patel is the CEO of Replimune.
369 people are employed at Replimune.
Replimune is based in Woburn, Massachusetts.
The NAICS codes for Replimune are [54, 541714, 541, 54171, 5417].
The SIC codes for Replimune are [873, 87].